Banner for leaf pages 2


Also known as Torisel

Temsirolimus (CCI-779) is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in late May 2007, and was also approved by the European Medicines Agency (EMEA) on November 2007. It is a derivative of sirolimus and is sold as Torisel.

Source: Wikipedia

What is it prescribed for?

Patients are most commonly prescribed temsirolimus to treat kidney cancer, metastatic cancer, blastomycosis, and rabies.

Ajax-loader Loading...